Rexford Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Buy
1,675
+19
+1% +$19.4K 1.23% 14
2026
Q1
$1.52M Buy
1,656
+68
+4% +$68.9K 1.09% 20
2025
Q4
$1.71M Buy
1,588
+5
+0.3% +$4.78K 1.29% 13
2025
Q3
$1.21M Buy
1,583
+95
+6% +$70.7K 0.93% 21
2025
Q2
$1.16M Buy
+1,488
New +$1.16M 0.96% 20

Other funds holding LLY

Rexford Capital's LLY Position: Q2 2026 in Review

Rexford Capital increased its Eli Lilly (LLY) stake by 1.1% in Q2 2026, buying an estimated $19.4K and bringing the position to 1,675 shares worth $2.01M. The position accounts for 1.23% of the portfolio, ranked #14.

Rexford Capital first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rexford Capital held 1,675 shares of Eli Lilly worth $2.01M as of Q2 2026.
  • Rexford Capital bought 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up 1.23% of Rexford Capital's portfolio in Q2 2026, its #14 holding.
  • Rexford Capital first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.